Diabetes and Cancer

Diabetes and malignant growth are predominant ailments with high effect on wellbeing around the world. Epidemiologic observer proposes that individuals with diabetes are at altogether higher hazard for some types of malignancy. Type 2 diabetes and malignancy share a few hazard factors, however conceivable biologic connections between the two infections are not entirely comprehended. Besides, observer from observational investigations recommends that a few meds used to treat hyperglycemia are connected with either expanded or decreased danger of malignant growth.

 

    Related Conference of Diabetes and Cancer

    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 18-19, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 18-19, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland

    Diabetes and Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in